Artificial, a Palo Alto-based startup, just announced a $21.5M funding round, including investment from M12, Microsoft’s venture fund, to further develop and commercialize its lab automation software.

As regulatory requirements continue to evolve, and instrumentation becomes more sophisticated, laboratories find themselves managing increasing amounts of data, a comprehensive data management plan, ...

Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost ...

Bruker Corporation BRKR recently entered into a definitive agreement to acquire a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions, Chemspeed Technologies AG. This ...

Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...